Abortion pill fight may have broader implications for FDA drug approval

A federal judge is being asked in a lawsuit to direct the agency to rescind its approval of mifepristone, one of two drugs used in medication abortions — a move that would be unprecedented.

View original article
Contributor: Rachel Roubein